NBF Grantee, Hall of Fame Member Publish Research in Blood, Journal of the Neurological Sciences

Two past recipients of National Blood Foundation (NBF) early-career Scientific Research Grants recently published research in peer-reviewed journals. 

In Blood, Eldad A. Hod, MD, a 2020 NBF Hall of Fame member and 2011 grant recipient; and David Roh, MD, a 2020 NBF recipient, published research that found transfusing ABO-incompatible platelets may result in lower platelet recovery and increased odds of mortality in patients with intracerebral hemorrhage (ICH). “The findings suggest the importance of ABO compatibility for platelet transfusions for ICH,” Hod, Roh and their colleagues wrote, “but further investigation into the mechanism underlying these observations is required.”

Roh also published research in the Journal of the Neurological Sciences. Roh, as part of an expert group of neurologists and hematologists, conducted a collaborative, comprehensive review of literature related to vaccine-induced immune thrombotic thrombocytopenia (VITT). VITT may include cerebral venous thromboses (CVT) and been described following vaccination with AstraZeneca and Johnson and Johnson vaccines for COVID-19. Roh and his colleagues determined that strategies for rapid evaluation and treatment of the CVT in the context of possible VITT exist, including inflammatory marker measurements, PF4 assays and non-heparin anticoagulation.

An NBF grant is a career milestone for many investigators early in their careers and often validates their research scope as their career trajectory is taking shape. This funding inspires innovation in the field for many years. 

Please consider making a gift today to support early-career investigators and their important work. Future medical breakthroughs to improve patient and donor care depend on it.